Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 Associated Encephalopathy/Encephalitis and Multi-systemic Inflammatory Syndrome in Children

NCT05576714 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT05576714
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05576714 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Prognostic Biomarkers, Host Factors and Viral Factors for COVID-19 Associated Encephalopathy/Encephalitis and Multi-systemic Inflammatory Syndrome in Children
Lead sponsor
National Taiwan University Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2022
Completion date
July 31, 2025
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19-associated encephalitis, multisystem inflammatory syndrome in children